The first keynote session for the 2025 BenefitsPRO Broker Expo is: "It's Not Personal, It's Just Healthcare,"a fireside chat about a documentary that aims to dispel commonly held health care myths and to expose the problems, flaws, and fallacies that exist within the current health care and health insurance systems.
The ERISA Industry Committee sues to stop new Biden administration mental health regulations issued in 2024, saying they are “arbitrary and capricious” and employers cannot certify compliance “due to vague, undefined terms."
In addition to the $40 million Vanguard agreed to pay to investors as part of a class action suit in November, the SEC now finds that the firm did not provide retail investors accurate information about the capital gains and tax implications of a change to investment minimums.
SECURE 2.0 extended the catch-up limit for people between ages 60 and 63, but 55% of eligible savers aren't even aware that they have this opportunity, according to a new Guideline survey.
Instant Insights /
The Prescription Drug Problem & PBM Reform
Various pieces of health care transparency legislation have identified areas requiring employers to meet their fiduciary responsibilities, such as designing an evaluation process for selecting vendors to deploy their health and welfare benefits strategy.
A new Investment Company Institute national ad campaign attempts to mobilize 120 million Americans “to protect retirement savings” by urging Congress to extend the 2017 Tax Cuts and Jobs Act, set to expire at the end of 2025.
Top career regrets include not asking for a pay increase (6%), not prioritizing work-life balance (59%), staying at a job too long (58%) and not negotiating salary when taking a job (58%).
In the latest Securities and Exchange Commission off-channel communications sweep, 12 firms will pay hefty fines because they used unapproved communication methods, such as WhatsApp, and failed to properly keep records.
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.
Whether it’s exploring new funding models, leveraging carrier innovations, or simplifying benefits delivery, advisors play a critical role in enabling employers to navigate the shifting landscape.